From trivalent to quadrivalent influenza vaccines: Public health and economic burden for different immunization strategies in Spain-Reference-Cited by-同舟云学术

From trivalent to quadrivalent influenza vaccines: Public health and economic burden for different immunization strategies in Spain

Published:2020-05-21 Issue:5 Volume:15 Page:e0233526
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Crépey Pascal^ORCID,Redondo Esther,Díez-Domingo Javier,Ortiz de Lejarazu Raúl^ORCID,Martinón-Torres Federico,Gil de Miguel Ángel,López-Belmonte Juan Luis,Alvarez Fabián P.^ORCID,Bricout Hélène,Solozabal Míriam

Funder

Sanofi Pasteur

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference68 articles.

1. World Health Organization [Internet]. Influenza (Seasonal); c2018 [cited 2019]. Available from: https://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal).

2. The burden of influenza B: a structured literature review.;W Paul Glezen;American journal of public health,2013

3. Instituto de Salud Carlos III [Internet]. Sistema de Vigilancia de la Gripe en España; c2017-2018 [cited 2019]. Available from: http://vgripe.isciii.es/inicio.do.

4. Gobierno de Aragón [Internet]. Vigilancia de la Gripe; c2001-2018 [cited 2019]. Available from: https://www.aragon.es/-/vigilancia-de-la-gripe.

5. Instituto de Salud Carlos III [Internet]. Informe de Vigilancia de la Gripe en España, Temporada 2017–2018; c2017-2018 [cited 2019]. Available from: http://www.isciii.es/ISCIII/es/contenidos/fd-servicios-cientifico-tecnicos/fd-vigilancias-alertas/fd-enfermedades/fd-gripe/fd-informes-semanales-vigilancia-gripe/pdfs_2017-2018/Informe_Vigilancia_GRIPE_2017-2018_27julio2018.pdf.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunogenicity and Safety of an Inactivated Quadrivalent Influenza Vaccine Administered Concomitantly with a 23-Valent Pneumococcal Polysaccharide Vaccine in Adults Aged 60 Years and Older;Vaccines;2024-08-22

2. Tetravalent SARS-CoV-2 S1 subunit protein vaccination elicits robust humoral and cellular immune responses in SIV-infected rhesus macaque controllers;mBio;2023-10-31

3. Immunogenicity and safety of inactivated quadrivalent influenza vaccine compared with the trivalent vaccine for influenza infection: an overview of systematic reviews;BMC Infectious Diseases;2023-08-29

4. An Economic Comparison in the Elderly of Adjuvanted Quadrivalent Influenza Vaccine with Recombinant Quadrivalent Influenza Vaccine in Spain;Vaccines;2023-02-13

5. Trivalent SARS-CoV-2 S1 Subunit Protein Vaccination Induces Broad Humoral Responses in BALB/c Mice;Vaccines;2023-01-31